Skip to content 
Stubborn weight, uncontrolled appetite, and metabolic challenges create frustration when traditional diet and exercise aren’t enough. GLP-1 Peptide Weight Program at Fond & Faye in Rutherford, NJ, provides medically supervised weight loss through advanced peptide therapy that regulates appetite, improves metabolic function, and promotes significant fat loss. This prescription weight management program uses GLP-1 receptor agonist medications that mimic natural hormones controlling hunger and blood sugar. Whether you’ve struggled with weight for years or need medical support for sustainable results, this clinically proven treatment provides the solution.
The GLP-1 Peptide Weight Program is a medically supervised weight loss treatment using GLP-1 receptor agonist medications. These peptides mimic a natural hormone that regulates appetite, slows digestion, and improves insulin function. The program combines prescription GLP-1 therapy with nutritional guidance, lifestyle coaching, and medical monitoring for comprehensive weight loss.
You’re an excellent candidate if you have a BMI of 30 or higher, or a BMI of 27+ with weight-related health conditions. Ideal candidates have struggled with traditional weight loss methods, are committed to lifestyle changes alongside medication, and don’t have contraindications like a history of certain thyroid cancers or pancreatitis. Pregnant or nursing women cannot use GLP-1 therapy.
Your program begins with a medical evaluation, including health history, physical exam, and lab work. We determine appropriate medication and dosing. You’ll learn proper injection technique for weekly self-administration. Regular follow-up appointments monitor your progress and adjust dosing. Nutritional counseling helps optimize your food choices. Most people see significant weight loss within the first months.
GLP-1 peptides work through multiple mechanisms. They activate receptors in your brain that reduce appetite and increase feelings of fullness. The medications slow gastric emptying, keeping you satisfied longer after meals. They improve insulin sensitivity and blood sugar regulation. The combined effects create a significant caloric deficit without constant hunger, resulting in substantial, sustainable weight loss.
GLP-1 therapy provides superior weight loss compared to traditional diet and exercise alone, with an average of 15-20% body weight reduction versus 5-10% with lifestyle changes. Unlike bariatric surgery, GLP-1 is non-invasive with no recovery time. Compared to older weight loss medications, GLP-1 peptides are more effective with better side effect profiles.
Maximize your results by following the dosing schedule consistently, eating protein-rich, nutrient-dense foods, staying well-hydrated, engaging in regular physical activity, getting adequate quality sleep, managing stress, attending all follow-up appointments, and being patient as results develop progressively. The medication makes lifestyle changes easier, but commitment to healthy habits optimizes results.
Common side effects include nausea, diarrhea, constipation, and decreased appetite, which are typically mild and improve as your body adjusts. Starting with low doses and increasing gradually minimizes side effects. Eating smaller meals and avoiding fatty foods helps reduce nausea. Serious side effects are rare. We monitor closely and adjust treatment if needed.
Clinical studies show average weight loss of 15-20% of starting body weight, though individual results vary. Most people notice significant appetite reduction within weeks, with steady weight loss throughout treatment. Results depend on starting weight, adherence, and lifestyle factors.
GLP-1 therapy is typically a long-term treatment. Most people regain weight if they stop medication, as the underlying hormonal regulation ends. Think of it like managing any chronic condition—continued treatment maintains benefits. Some people transition to lower maintenance doses after reaching their goal weight.
While some people successfully maintain weight loss after stopping, most regain weight as appetite regulation returns to baseline. The safest approach is viewing GLP-1 as long-term therapy, potentially at lower maintenance doses. Continued treatment typically provides the best long-term success.
